Subscribe to Breaking News emails

You have successfully subscribed to the Breaking News email.

Subscribe today to be the first to to know about breaking news and special reports.

Army Approves Hormone Therapy Treatment for Wikileaker Chelsea Manning

 / Updated 

Breaking News Emails

Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.

The U.S. Army has approved hormone therapy for Chelsea Manning, who was convicted of leaking national security secrets to Wikileaks, defense officials told NBC News late Thursday.

Private Manning revealed her gender identity as a transgender female after being convicted and sentenced to 35 years in the military prison at Leavenworth in July 2013.

According to the officials, since Manning has been clinically diagnosed as a transgender and is confined to the military prison, the Army is obligated to provide and pay for her hormone treatments — just as if she was confined to a civilian federal prison.

The hormone therapy development was first reported by USA TODAY.

Manning, formerly known as Bradley Manning, became the first military inmate to ask for treatment for gender dysphoria. She asked for a treatment plan that would consider three measures: dressing and living as a woman, hormone therapy and possible surgery.

In July 2014, Defense Secretary Chuck Hagel approved an Army recommendation to begin the early stages of gender reassignment, including counseling and approval to dress as a woman, officials said.

IN-DEPTH

— Jim Miklaszewski

Breaking News Emails

Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.

Breaking News Emails

Get breaking news alerts and special reports. The news and stories that matter, delivered weekday mornings.
MORE FROM news

Have feedback?

How likely are you to recommend nbcnews.com to a friend or colleague?

0 = Very unlikely
10 = Very likely
Please select answer

Is your feedback about:

Please select answer

Thank you!

Your feedback has been sent out. Please enjoy more of our content.

We appreciate your help making nbcnews.com a better place.